110 related articles for article (PubMed ID: 4029808)
21. Syntheses and inhibitory effects on gastric lesions of trans-guanidinomethylcyclohexane carboxylic acid arylamides.
Ueda H; Momoi Y; Ikeda T; Kakegawa H; Miyataka H; Matsumoto H; Satoh T
Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):522-4. PubMed ID: 8477502
[TBL] [Abstract][Full Text] [Related]
22. [Cetraxate in duodenal ulcer, a double-blind clinical study (author's transl)].
Yu JY; Wang TH; Wang CY; Chen RR; Sung JL
Taiwan Yi Xue Hui Za Zhi; 1981 Apr; 80(4):442-8. PubMed ID: 7031178
[No Abstract] [Full Text] [Related]
23. Anti-ulcer effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl) phenyl] propionic acid hydrochloride (TEI-5103).
Hoshina K; Yamazaki N; Takeshita T; Naruchi T
Arzneimittelforschung; 1985; 35(2):493-7. PubMed ID: 3873243
[TBL] [Abstract][Full Text] [Related]
24. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals.
Ueda F; Aratani S; Mimura K; Kimura K; Nomura A; Enomoto H
Arzneimittelforschung; 1984; 34(4):474-7. PubMed ID: 6540106
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic effects of cetraxate against acute gastritis and acute aggravation of chronic gastritis. Endoscopic investigation by the double-blind method.
Yamagata S; Miura K
Arzneimittelforschung; 1983; 33(8):1191-5. PubMed ID: 6357203
[TBL] [Abstract][Full Text] [Related]
26. Studies on the mechanism for the gastric mucosal protection by famotidine in rats.
Miyata K; Kamato T; Nishida A; Honda K
Jpn J Pharmacol; 1991 Feb; 55(2):211-22. PubMed ID: 2067140
[TBL] [Abstract][Full Text] [Related]
27. Gastric ulcer treatment with intravenous human epidermal growth factor: a double-blind controlled clinical study.
Itoh M; Matsuo Y
J Gastroenterol Hepatol; 1994; 9 Suppl 1():S78-83. PubMed ID: 7881024
[TBL] [Abstract][Full Text] [Related]
28. [Effects of cimetidine and cetraxate on the biosynthetic activity of mucus glycoproteins in organ culture of rat gastric mucosa (author's transl)].
Ishihara K; Ohara S; Azuumi Y; Hotta K; Kakei M; Okabe H
Nihon Shokakibyo Gakkai Zasshi; 1981 Oct; 78(10):1896-900. PubMed ID: 7328821
[No Abstract] [Full Text] [Related]
29. Tranexamic acid derivatives with enhanced absorption.
Svahn CM; Merenyi F; Karlson L; Widlund L; Grälls M
J Med Chem; 1986 Apr; 29(4):448-53. PubMed ID: 3959024
[TBL] [Abstract][Full Text] [Related]
30. Effect of p-hydroxyphenyl-propionic ester of tranexamic acid hydrochloride (Cetraxate) on peptic ulcer. Multi-center clinical study.
Ishimori A; Yamagata S; Taima T
Arzneimittelforschung; 1979; 29(10):1625-32. PubMed ID: 391240
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of cetraxate, a new antiulcer drug, against serotonin-induced ulcer.
Hashizume T; Aibara S; Hirokawa K; Nishida A; Ogawa H; Kasahara A
Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):314-27. PubMed ID: 508012
[TBL] [Abstract][Full Text] [Related]
32. Cetraxate improves ethanol-induced gastric mucosal congestion in anesthetized dogs.
Kawano S; Hayashi N; Tsuji S; Fusamoto H; Kamada T
Jpn J Pharmacol; 1992 Sep; 60(1):39-42. PubMed ID: 1460803
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of cimetidine and cetraxate in the treatment of peptic ulcer.
Archimandritis A; Tjivras M; Alexiou A; Bougas S; Fertakis A
J Clin Gastroenterol; 1991 Feb; 13(1):114-5. PubMed ID: 2007733
[No Abstract] [Full Text] [Related]
34. The preventative effect of the antifibrinolytic agents, epsilon-aminocaproic acid and tranexamic acid, on stress ulcer formation in rats.
Kodama Y; Kumashiro R; Gain T; Matsumoto T
Int Surg; 1983; 68(4):361-3. PubMed ID: 6668161
[TBL] [Abstract][Full Text] [Related]
35. Enzymatic preparation of D-beta-acetylthioisobutyric acid and cetraxate hydrochloride using a stereo- and/or regioselective hydrolase, 3,4-dihydrocoumarin hydrolase from Acinetobacter calcoaceticus.
Honda K; Kataoka M; Shimizu S
Appl Microbiol Biotechnol; 2002 Nov; 60(3):288-92. PubMed ID: 12436309
[TBL] [Abstract][Full Text] [Related]
36. Syntheses and inhibitory effects on gastric lesions of 4-guanidinomethylbenzoic acid arylamides.
Ueda H; Ikeda T; Kakegawa H; Miyataka H; Matsumoto H; Satoh T
Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1387-90. PubMed ID: 8403087
[TBL] [Abstract][Full Text] [Related]
37. Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.
Wu CJ; Hsu PI; Lo GH; Lo CC; Lin CK; Shie CB; Peng NJ; Tseng HH; Jou HS; Tsai PM; Chen A; Chen JL; Lai KH
J Chin Med Assoc; 2004 Apr; 67(4):161-7. PubMed ID: 15244013
[TBL] [Abstract][Full Text] [Related]
38. Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl] propionic acid hydrochloride on gastric mucosa directly from the lumen.
Hoshina K; Tanabe H; Yamazaki N; Yamamoto M; Ohba T; Takeshita T; Naruchi T
Arzneimittelforschung; 1987 Nov; 37(11):1289-95. PubMed ID: 3440038
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic effect of cetraxate on gastric ulcers (Phase I).
Ito S; Murakami T; Kambara T; Kishi S
Gastroenterol Jpn; 1979; 14(3):243-4. PubMed ID: 447004
[No Abstract] [Full Text] [Related]
40. [Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication].
Oka M; Ichinose M; Fujishiro M; Omata M
Nihon Rinsho; 2005 Nov; 63 Suppl 11():461-4. PubMed ID: 16363579
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
